We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Cervical Pessary Reduces Rate of Preterm Birth

By HospiMedica International staff writers
Posted on 28 Dec 2017
A new study suggests that using a cervical pessary in pregnant women with short cervical length reduces the risk of spontaneous early birth.

Researchers at the University of Naples Federico II (Italy) conducted a randomized clinical trial of 300 women with singleton gestations, no previous spontaneous preterm births, and cervical lengths of 25 mm (or less) at 18-24 weeks of gestation, in order to test if use of a cervical pessary would reduce the rate of spontaneous preterm birth (less than 34 weeks of gestation). More...
In the 150 women in the study group the pessary was removed at week 36-37, or earlier if indicated. The primary endpoint was spontaneous preterm birth at less than 34 weeks of gestation.

The results showed that the primary end point of pre-term birth occurred in 11 women (7.3%) in the pessary group, and 23 women (15.3%) in the control group. The majority of women in both the study and the control groups were also treated with vaginal progesterone. The researchers found that during follow-up, the women in the pessary group had a higher rate of increased or new vaginal discharge (86.7%) versus 46% in the control group. The study was published on December 19, 2017, in JAMA.

“Among women without prior spontaneous preterm birth who had asymptomatic singleton pregnancies and short transvaginal cervical length, use of a cervical pessary, compared with no pessary use, resulted in a lower rate of spontaneous preterm birth at less than 34 weeks of gestation,” concluded lead author Gabriele Saccone, MD, and colleagues. “The results of this single-center, non-blinded study among selected pregnant women require confirmation in multicenter clinical trials.”

“Based on these data, clinicians might contemplate recommending pessaries for all women with a short cervix identified on an antenatal sonogram,” wrote Robert Silver, MD, and D. Ware Branch, MD, of the University of Utah (Salt Lake City, USA), in an accompanying editorial. “Nonetheless, it is important to be cautious prior to universal adoption of pessaries. In contrast to the results of the current trial, another study conducted with equivalent scientific rigor found no benefit to use of a pessary in women with short cervixes.”

Pregnant women are at risk of preterm birth when the cervix begins to efface (shorten) and dilate earlier than necessary. One of the options to prevent a late miscarriage or preterm birth is the cervical pessary, a small silicone ring-shaped device placed around the incompetent cervix early in the pregnancy in order to close it; it is removed later on when the risk of a preterm birth has passed. Other options include a cerclage suture stitched around the opening of the cervix around 12–14 weeks into the pregnancy.

Related Links:
University of Naples Federico II


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
ow Frequency Pulse Massager
ET10 L
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.